Ignite Creation Date:
2024-05-05 @ 5:13 PM
Last Modification Date:
2024-10-26 @ 9:29 AM
Study NCT ID:
NCT00412750
Status:
TERMINATED
Last Update Posted:
2011-07-13
First Post:
2006-12-15
Brief Title:
Efficacy and Safety of Telbivudine in Treatment naïve Patients With Hepatitis B e Antigen HBeAg-Positive Chronic Hepatitis B CHB
Sponsor:
Novartis
Organization:
Novartis
Organization Data
Organization:
Novartis
Class:
INDUSTRY
Study ID:
CLDT600A2406
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Novartis
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
novartis
Old Organization:
novatis